Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
GSK-4406371A by GSK for Rubella (German Measles): Likelihood of Approval
GSK-4406371A is under clinical development by GSK and currently in Phase II for Rubella (German Measles). According to GlobalData, Phase...
GSK-4406371A by GSK for Mumps: Likelihood of Approval
GSK-4406371A is under clinical development by GSK and currently in Phase II for Mumps. According to GlobalData, Phase II drugs...
GSK-4406371A by GSK for Measles: Likelihood of Approval
GSK-4406371A is under clinical development by GSK and currently in Phase II for Measles. According to GlobalData, Phase II drugs...